Pages that link to "Q77493218"
Jump to navigation
Jump to search
The following pages link to Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients (Q77493218):
Displaying 50 items.
- Cysteine proteinase inhibitor cystatin C in squamous cell carcinoma of the head and neck: relation to prognosis (Q24646038) (← links)
- Functional structure of the somatomedin B domain of vitronectin (Q24648799) (← links)
- A multigene RT-PCR assay used to predict recurrence in early breast cancer: two presentations with contradictory results (Q24806350) (← links)
- Molecular Imaging of Biomarkers in Breast Cancer (Q26772870) (← links)
- Platelets, coagulation and fibrinolysis in breast cancer progression (Q26823716) (← links)
- Candidate prognostic markers in breast cancer: focus on extracellular proteases and their inhibitors (Q26830522) (← links)
- Insidious changes in stromal matrix fuel cancer progression (Q26851261) (← links)
- How vitronectin binds PAI-1 to modulate fibrinolysis and cell migration (Q27641436) (← links)
- Plasminogen Activator System and Breast Cancer: Potential Role in Therapy Decision Making and Precision Medicine (Q28067626) (← links)
- HER2 and uPAR cooperativity contribute to metastatic phenotype of HER2-positive breast cancer (Q28085413) (← links)
- Relevance of breast cancer cell lines as models for breast tumours: an update (Q28242046) (← links)
- Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond (Q28388487) (← links)
- Breast cancer metastasis: markers and models (Q29618061) (← links)
- Prospective evaluation of prognostic factors uPA/PAI-1 in node-negative breast cancer: phase III NNBC3-Europe trial (AGO, GBG, EORTC-PBG) comparing 6×FEC versus 3×FEC/3×Docetaxel (Q30318419) (← links)
- Dependence on endocytic receptor binding via a minimal binding motif underlies the differential prognostic profiles of SerpinE1 and SerpinB2 in cancer (Q30502082) (← links)
- Microvessel density as a prognostic factor in non-small-cell lung carcinoma: a meta-analysis of individual patient data (Q31113128) (← links)
- Prognostic significance of urokinase plasminogen activator and plasminogen activator inhibitor-1 mRNA expression in lymph node- and hormone receptor-positive breast cancer. (Q33255953) (← links)
- Increased expression of urokinase plasminogen activator and its cognate receptor in human seminomas (Q33559079) (← links)
- Plasminogen activator urokinase expression reveals TRAIL responsiveness and supports fractional survival of cancer cells (Q33695003) (← links)
- Optimal approach in early breast cancer: Adjuvant and neoadjuvant treatment (Q33698446) (← links)
- Cleavage of the urokinase receptor (uPAR) on oral cancer cells: regulation by transforming growth factor - β1 (TGF-β1) and potential effects on migration and invasion. (Q33709060) (← links)
- Breast cancer and metabolic syndrome linked through the plasminogen activator inhibitor-1 cycle (Q33715393) (← links)
- Ginkgolic acids inhibit migration in breast cancer cells by inhibition of NEMO sumoylation and NF-κB activity (Q33798749) (← links)
- Krüppel-like factor 17 inhibits urokinase plasminogen activator gene expression to suppress cell invasion through the Src/p38/ MAPK signaling pathway in human lung adenocarcionma (Q33888940) (← links)
- Assessment of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in Breast Cancer Tissue: Historical Aspects and Future Prospects (Q34095769) (← links)
- Experience in Phase I Trials and an Upcoming Phase II Study with uPA Inhibitors in Metastatic Breast Cancer (Q34095789) (← links)
- Proteins and carbohydrates in nipple aspirate fluid predict the presence of atypia and cancer in women requiring diagnostic breast biopsy (Q34148127) (← links)
- The prognostic value of the human kallikrein gene 9 (KLK9) in breast cancer. (Q34194117) (← links)
- Individual participant data meta-analysis of prognostic factor studies: state of the art? (Q34244162) (← links)
- Node-Negative Breast Cancer: Which Patients Should Be Treated? (Q34284270) (← links)
- Common protein biomarkers assessed by reverse phase protein arrays show considerable intratumoral heterogeneity in breast cancer tissues (Q34336095) (← links)
- Targeting tumor cell invasion and dissemination in vivo by an aptamer that inhibits urokinase-type plasminogen activator through a novel multifunctional mechanism (Q34434875) (← links)
- Role of urokinase plasminogen activator and plasminogen activator inhibitor mRNA expression as prognostic factors in molecular subtypes of breast cancer (Q34653166) (← links)
- Host plasminogen activator inhibitor-1 promotes human skin carcinoma progression in a stage-dependent manner. (Q34725029) (← links)
- In vivo anti-metastatic effects of uPAR retargeted measles virus in syngeneic and xenograft models of mammary cancer (Q34997475) (← links)
- Prognostic and Predictive Markers for Treatment Decisions in Early Breast Cancer (Q35095603) (← links)
- Plasminogen activation at the cell surface (Q35107627) (← links)
- Reporting of prognostic markers: current problems and development of guidelines for evidence-based practice in the future (Q35108252) (← links)
- Tumor markers: from laboratory to clinical utility (Q35157034) (← links)
- Matrix remodeling stimulates stromal autophagy, "fueling" cancer cell mitochondrial metabolism and metastasis (Q35159014) (← links)
- uPA and PAI-1 as biomarkers in breast cancer: validated for clinical use in level-of-evidence-1 studies (Q35580701) (← links)
- Markers of increased risk for failure of adjuvant therapies (Q35601631) (← links)
- Multivariate meta-analysis of individual participant data helped externally validate the performance and implementation of a prediction model. (Q35682635) (← links)
- uPAR and HER-2 gene status in individual breast cancer cells from blood and tissues (Q35720929) (← links)
- Plasminogen binding and activation at the breast cancer cell surface: the integral role of urokinase activity (Q35749341) (← links)
- Biomolecular features of clinical relevance in breast cancer. (Q35750303) (← links)
- Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review (Q35904441) (← links)
- Utilizing prognostic and predictive factors in breast cancer (Q36046256) (← links)
- Breast cancer as an acquired thrombophilic state (Q36092001) (← links)
- uPAR enhances malignant potential of triple-negative breast cancer by directly interacting with uPA and IGF1R. (Q36097941) (← links)